Neurourology and Urodynamics
© Wiley Periodicals, Inc.
Edited By: Roger Dmochowski
Impact Factor: 3.128
ISI Journal Citation Reports © Ranking: 2015: 18/77 (Urology & Nephrology)
Online ISSN: 1520-6777
NIH Public Access Mandate
For those interested in the Wiley-Blackwell policy on the NIH Public Access Mandate, please visit our policy statement
For additional tools visit Author Resources - an enhanced suite of online tools for Wiley InterScience journal authors, featuring Article Tracking, E-mail Publication Alerts and Customized Research Tools.
Neurourology and Urodynamics welcomes original contributions from all parts of the world on urinary tract function, urinary and fecal continence and pelvic floor function. These can be submitted online at: http://mc.manuscriptcentral.com/neurourol
We are working with the WebCONSORT team on a research study designed to improve the reporting of randomised controlled trials. As such, by submitting your manuscript to our journal you may later be asked to participate in this research, but your decision will not impact on any future acceptance or rejection of your manuscript.
Authors are encouraged to check for an existing account. If you are submitting for the first time, and you do not have an existing account, then create a new account. Once you have logged in, you will be presented with the Main Menu and a link to your Author Center. Enter your Author Center to submit your manuscript. At the end of a successful submission, a confirmation screen with manuscript number will appear and you will receive an e-mail confirming that the manuscript has been received by the journal. If you have any questions, do not hesitate to contact us at email@example.com or contact ScholarOne Support at firstname.lastname@example.org.
Editorial Office: Roger Dmochowski, Neurourology and Urodynamics Editorial Office, ROOM A 1302 Medical Center North, Dept of Urology, Vanderbilt Medical Center, Nashville, TN 37232 Email: email@example.com
Note: Effective with the 2016 volume, this journal will be published in an online-only format. Print subscription and single issue sales are available from Wiley’s Print-on-Demand Partner. To order online click through to the ordering portal from the journal’s subscribe and renew page.
Submissions must contain the following required elements:
DISCLOSURE STATEMENT. The required form can be downloaded from the website.
CLINICAL TRIAL REGISTRATION NUMBER. Must be provided in a cover letter. See ‘Category of Submissions’ section on original clinical articles for more information.
AUTHOR CONTRIBUTIONS. To be an author, a person must have made substantive intellectual contributions to a published study. The specific contributions of all authors must be clearly specified in a cover letter. The following criteria must all be fulfilled: 1) Substantial contributions to conception and design, 2) Drafting and revising the article critically for important intellectual content, 3) Final approval of the version to be published. All contributors not meeting these criteria for authorship should instead be listed in the acknowledgements section.
PUBLICATION STATUS. Work must not have been published before, with the exception of standardisation reports, summary reports on Cochrane meta-analyses, etc. in which case pre-publication will be expected to be fully acknowledged in a cover letter.
TITLE PAGE. This must be submitted as a separate file from the main document to allow for double-blind peer review. It must contain the complete title of the paper, the names, the titles, and affiliations of all authors; the institution at which the work was performed; the name, address, and telephone number for all correspondence; and a short title to be used as a running head. It must also indicate the word count for the text only (excluding abstract, acknowledgments, figure legends, and references).
ABSTRACT. This should be an actual condensation of the entire work and formatted as follows: 1) Aims, 2) Methods, 3) Results, 4) Conclusions. The abstract should not exceed 250 words.
KEYWORDS. Supply a list of keywords or phrases (not in the title) that will adequately index the subject matter of the article. These should preferably be standard MeSH indexing words.
TEXT. The manuscript must be prepared using the American or English style. The text should follow the format: Introduction, Materials and Methods, Results, Discussion, and Conclusions. Subheadings and paragraph titles are permissible for clarity. Acknowledgments should be listed immediately prior to the References. Authors whose first language is not English should consider review of the manuscript by a reader familiar with idiomatic English prior to submission or the use of Wiley Editing services: http://wileyeditingservices.com/en/
TABLES AND FIGURES. A maximum of 5 table and figures are allowed. These are to be numbered in order with Arabic numbers. Please be sure to submit these as separate files in TIFF or EPS file format. A legend must be provided for each illustration and must define all abbreviations used therein. Legends should be placed at the end of the manuscript text file.
PERMISSIONS. If photographs of human subjects are used no identifiers are allowed. A copy of a signed consent form must accompany the manuscript if any distinguishing features are shown. Letters of permission from the original publisher and/or author must be submitted with any material that has previously been published.
FUNDING. Research funders must be listed at the end of the document. Funding for any publication should be clearly stated, and the role of the research funder as well as all parties contributing to all aspects of the research and its subsequent publication, must be made clear.
REVISIONS. When submitting a revision of a submission, authors must submit one version of the paper showing ‘tracking changes’ or changes in bold, and one version without. All of the reviewer’s queries must also be answered in the ‘Response to Reviewers’ section of Manuscript Central.
AMA – American Medical Association
All references should be numbered consecutively in order of appearance and should be as complete as possible. In text citations should cite references in consecutive order using Arabic superscript numerals. Sample references follow:
1. King VM, Armstrong DM, Apps R, Trott JR. Numerical aspects of pontine, lateral reticular, and inferior olivary projections to two paravermal cortical zones of the cat cerebellum. J Comp Neurol 1998;390:537-551.
2. Voet D, Voet JG. Biochemistry. New York: John Wiley & Sons; 1990. 1223 p.
Please note that journal title abbreviations should conform to the practices of Chemical Abstracts. For more information about AMA reference style - AMA Manual of Style
MANUSCRIPT FORMATTING :
For optimal production, prepare manuscript text in size 12 font on 8-1/2 x 11 inch page, with at least 1 inch margins on all sides.
The minimum requirements for digital resolution are:
- 1200 DPI/PPI for black and white images, such as line drawings or graphs.
- 300 DPI/PPI for picture-only photographs
- 600 DPI/PPI for photographs containing pictures and line elements, i.e., text labels, thin lines, arrows.
These resolutions refer to the output size of the file; if you anticipate that your images will be enlarged or reduced, resolutions should be adjusted accordingly.
For the editorial review process EPS or TIFF files will be required in RGB color. Delivery of these production-quality files early in the review process may facilitate smooth and rapid publication once a manuscript has been accepted.
SUPPORTING INFORMATION :
Supporting Information can be a useful way for an author to include important but ancillary information with the online version of an article. Examples of Supporting Information include additional tables, data sets, figures, movie files, audio clips, 3D structures, and other related nonessential multimedia files. Supporting Information should be cited within the article text, and a descriptive legend should be included. It is published as supplied by the author, and a proof is not made available prior to publication; for these reasons, authors should provide any Supporting Information in the desired final format. For further information on recommended file types and requirements for submission, please visit: http://authorservices.wiley.com/bauthor/suppinfo.asp
CATEGORY OF SUBMISSIONS :
The Journal accepts papers prepared in any one of the following forms listed below. For clinical papers dealing with the treatment of urinary incontinence and/or pelvic organ prolapse, preference will be given to papers whose methodology and terminology adheres to existing ICS and SUFU guidelines (www.icsoffice.org and www.sufuorg.com).
State of the art review articles. Review articles are designed to provide an up-to-date review of the most modern and reasonable approach to a particular topic by a recognized expert in the field. They represent the authors' editorial point of view rather than a litany of dogma or an exhaustive compilation of all prior work in that field. These should not exceed 3000 words and 50 references.
Authors of systematic reviews must include a PRISMA checklist as part of their submission. Further details of the PRISMA requirements, flow charts and a Word version of the checklist are available at: http://www.prisma-statement.org/ The checklist is also available to download from the Neurourology & Urodynamics ScholarOne Manuscripts website during paper submission.
Original basic science articles and original clinical articles. These should not exceed 3000 words and 25 references. The clinical trial registration number must be reported in the cover letter for all submissions of clinical trial articles. Trials that are not registered will not be published, consistent with the International Committee of Medical Journal Editors’ Uniform Requirements ( www.icmje.org ). Authors are also encouraged to consult reporting guidelines relevant to their specific research design. For reports of randomized controlled trials authors must refer to the CONSORT statement ( www.consort-statement.org ).
Sounding board. This section is appropriate for papers that present an opinion, point of view, new concept, idea or editorial. They will be reviewed by the Editor in Chief, Associate Editors, and, when appropriate, they may be assigned to other reviewers. As far as possible the editors will respect the editorial integrity and style of the author.
Controversies in neurourology. Controversial topics will be presented by two or more authors who take different points of view. The authors will be solicited by the core editorial team and the discussion moderated by the Editor in Chief.
Letters to the editor. Pertinent letters of interest to the readership should not exceed 800 words. Peer-review will consist of approval by the Editor in Chief and a response from the author of any paper the letter comments on. If the letter does not follow the above guidelines, it will have to be submitted for formal peer review.
Editorial Comments. If it is appropriate for an editorial comment to accompany a particular article, this will be solicited by the core editorial team. Editorial comments should not exceed 500-600 words.
NB. Unfortunately, we cannot accept Case Reports.
ETHICAL CONSIDERATIONS :
Neurourology and Urodynamics believes in ethical behavior and supports the ICMJE Uniform Requirements (www.icmje.org ) the CONSORT statement ( www.consort-statement.org ) and the COPE guidelines ( www.publicationethics.org.uk ).
The Editor In Chief and Associate Editors have full responsibility and independence in both intellectual and practical terms to determine the content and academic direction of the journal, with particular reference to the validity of work and its importance to journal readers. All articles will be peer-reviewed in a blinded fashion. Supervision of the review process will either be via the Editor in Chief or a designated Associate Editor. We aim to have a minimum of two reviews carried out and often more than this. Reviewers’ opinions are relied upon heavily, but the final decision as to what is published rests with the core editorial team. All authors have the right to appeal editorial decisions and we are always willing to receive and deal with these. Corrections of errors (where they affect the interpretation of data or information) will be published as referenced errata.
Neurourology and Urodynamics employs a plagiarism detection system. By submitting your manuscript to this journal, you accept that your manuscript may be screened for plagiarism against previously published works.
Scientific Fraud. Whenever scientific fraud of any sort, including dual publication, is suspected, it should be reported back to the Editor in Chief, who will then discuss it with the Associate Editors and if there is a strong case that fraud has occurred, then the author will be contacted. Unless there is a satisfactory explanation, then they will be censured by contacting the Dean of their institution with the facts as they exist, and instituting immediate embargo on any further work from them for a minimum of two years. Consideration will also need to be given to contacting editors of other major urological journals to inform them of this problem, on a confidential basis.
All manuscripts submitted to Neurourology and Urodynamics must be submitted solely to this journal and may not have been published in any part or form in another publication of any type, professional or lay, and become the property of the publisher. On acceptance of a manuscript for publication, authors will be asked to transfer copyright to the publisher, who reserves copyright. No published material may be reproduced or published elsewhere without the written permission of the publisher and the author. The Journal will not be responsible for the loss of manuscripts at any time. All statements in, or omissions from, published manuscripts are the responsibility of the authors, who will assist the editors by reviewing proofs before publication. Reprint order forms will be sent with the proofs. No page charges will be levied against authors or their institutions for publication in this journal.
COPYRIGHT and ONLINE OPEN:
If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper.
For authors signing the copyright transfer agreement:
If the OnlineOpen option is not selected the corresponding author will be presented with the copyright transfer agreement (CTA) to sign. The terms and conditions of the CTA can be previewed in the samples associated with the Copyright FAQs: http://authorservices.wiley.com/bauthor/faqs_copyright.asp
For authors choosing OnlineOpen:
If the OnlineOpen option is selected the corresponding author will have a choice of the following Creative Commons License Open Access Agreements (OAA):
- Creative Commons Attribution
- Non-Commercial License OAA
- Creative Commons Attribution Non-Commercial -NoDerivs License OAA
To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services http://authorservices.wiley.com/bauthor/faqs_copyright.asp and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html.
If you select the OnlineOpen option and your research is funded by The Wellcome Trust and members of the Research Councils UK (RCUK) you will be given the opportunity to publish your article under a CC-BY license supporting you in complying with Wellcome Trust and Research Councils UK requirements. For more information on this policy and the Journal’s compliant self-archiving policy please visit: http://www.wiley.com/go/funderstatement.
For RCUK and Wellcome Trust authors click on the link below to preview the terms and conditions of this license: Creative Commons Attribution License OAA To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services http://authorservices.wiley.com/bauthor/faqs_copyright.asp and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html.
?? Production Questions ??